# Familial risk of Wolff–Parkinson–White syndrome: a nationwide family study in Sweden

**Authors:** Fabrizio Ricci, Mirnabi Pirouzifard, Kristian Galanti, Jan Sundquist, Kristina Sundquist, Richard Sutton, Artur Fedorowski, Bengt Zöller

PMC · DOI: 10.1093/europace/euaf285 · Europace · 2025-11-08

## TL;DR

This study finds that siblings of individuals with Wolff–Parkinson–White syndrome have a higher risk of developing the condition and related arrhythmias, suggesting a genetic component.

## Contribution

The study provides evidence of familial aggregation and hereditary contribution to Wolff–Parkinson–White syndrome using a nationwide Swedish cohort.

## Key findings

- Siblings of WPW patients have a four-fold higher risk of WPW diagnosis.
- Siblings show increased risks of atrial fibrillation and ventricular arrhythmias.
- All-cause mortality is not significantly different between siblings of WPW patients and the general population.

## Abstract

Wolff–Parkinson–White (WPW) syndrome is a rare cardiac disorder that predisposes to supraventricular arrhythmias. Prognosis is usually benign, yet there is an increased lifetime risk of sudden death. While typically sporadic, familial clustering has been reported. This study aimed to assess the risk of WPW, arrhythmias, and mortality among siblings of individuals with WPW.

This population-based sibling cohort included 5 338 434 individuals born in Sweden (1932–2018), with 3172 WPW cases identified from the Swedish National Patient Registers. Familial risks among siblings were assessed using incidence rate ratios (IRRs) and adjusted subdistributional hazard ratios (SHRs). Sensitivity analyses excluded syndromic WPW and cases without electrophysiologic procedural confirmation. Although familial occurrence of WPW was exceedingly rare with only 14 of 3172 cases (0.4%; ≈0.0003% of the total population), siblings of affected individuals showed a significantly higher rate of WPW diagnosis (0.121 vs. 0.032 per 1000 person-years; IRR 3.83; 95% CI 2.27–6.46; P < 0.001) translating to an almost four-fold higher adjusted risk (SHR 3.79; 95% CI 1.81–7.97; P < 0.001). Risks of atrial fibrillation (SHR 1.19; 95% CI 1.05–1.35; P < 0.01) and ventricular arrhythmias (SHR 1.84; 95% CI 1.45–2.35; P < 0.001) were also higher, whereas all-cause mortality was comparable irrespective of sibling history (HR 1.01; 95% CI 0.92–1.11; P = 0.88).

WPW features familial aggregation and increased arrhythmic risk among siblings of affected individuals despite its extremely low absolute frequency in the general population. The evidence of a measurable hereditary component within an otherwise sporadic, non-syndromic condition points to a genetic contribution driven by complex inheritance patterns.

Graphical Abstract

## Linked entities

- **Diseases:** Wolff–Parkinson–White syndrome (MONDO:0008685), atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** arrhythmias (MESH:D001145), atrial fibrillation (MESH:D001281), Wolff-Parkinson-White (WPW) syndrome (MESH:D014927), arrhythmic (OMIM:212500), sudden death (MESH:D003645), cardiac disorder (MESH:D006331)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12635823/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12635823/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12635823/full.md

---
Source: https://tomesphere.com/paper/PMC12635823